What Does the Generalist Need to Know About HIV Infection?

被引:5
作者
Gallant, Joel E. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Infect Dis, Dept Med & Epidemiol, Baltimore, MD 21205 USA
关键词
HIV; Antiretroviral therapy; Primary care; Expertise; HUMAN-IMMUNODEFICIENCY-VIRUS; PHYSICIAN EXPERIENCE; ANTIRETROVIRAL THERAPY; MEDICINE ASSOCIATION; DISEASES-SOCIETY; UNITED-STATES; CARE; RECOMMENDATIONS; GUIDELINES; MANAGEMENT;
D O I
10.1053/j.ackd.2009.08.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Despite recent improvements in the efficacy, safety, tolerability, and convenience of antiretroviral therapy for patients, the management of HIV infection remains complex for clinicians. Multiple studies have shown better clinical outcomes and lower cost of care when HIV-infected patients are managed by experts. However, generalists are frequently involved in the care of patients with HIV infection, in many cases providing primary care in collaboration with an HIV expert. Generalists also play a critical role in the diagnosis and prevention of HIV infection. Generalists managing HIV-infected patients should be aware of the components of the initial patient evaluation. They should be familiar with the general principles of antiretroviral therapy and opportunistic infection prevention. They should be able to recognize antiretroviral toxicity and should be aware of common drug-drug interactions involving antiretroviral agents. (C) 2010 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:5 / 18
页数:14
相关论文
共 25 条
  • [1] Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
    Aberg, Judith A.
    Kaplan, Jonathan E.
    Libman, Howard
    Emmanuel, Patricia
    Anderson, Jean R.
    Stone, Valerie E.
    Oleske, James M.
    Currier, Judith S.
    Gallant, Joel E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 651 - 681
  • [2] [Anonymous], 14 C RETR OPP INF FE
  • [3] [Anonymous], 5 IAS C HIV PATH TRE
  • [4] [Anonymous], 2008, DEP HLTH HUMAN SERVI, P1
  • [5] [Anonymous], 16 C RETR OPP INF FE
  • [6] [Anonymous], 16 C RETR OPP INF FE
  • [7] Opt-out testing for human immunodeficiency virus in the United States - Progress and challenges
    Bartlett, John G.
    Branson, Bernard M.
    Fenton, Kevin
    Hauschild, Benjamin C.
    Miller, Veronica
    Mayer, Kenneth H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (08): : 945 - 951
  • [8] Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1
  • [9] Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P581
  • [10] Screening for HIV: A review of the evidence for the US Preventive Services Task Force
    Chou, R
    Huffman, LH
    Fu, RW
    Smits, AK
    Korthuis, PT
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 143 (01) : 55 - 73